Harbour Investments’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.6K | Sell |
|
|||||
|
2025
Q1 | $49.2K | Buy |
|
|||||
|
2024
Q4 | $3.92K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $5.96K | Hold |
|
|||||
|
2024
Q1 | $6.16K | Hold |
|
|||||
|
2023
Q4 | $5.73K | Hold |
|
|||||
|
2023
Q3 | $5.33K | Hold |
|
|||||
|
2023
Q2 | $5.68K | Hold |
|
|||||
|
2023
Q1 | $5.71K | Hold |
|
|||||
|
2022
Q4 | $5.66K | Hold |
|
|||||
|
2022
Q3 | $6K | Hold |
|
|||||
|
2022
Q2 | $6K | Buy |
|
|||||
|
2021
Q4 | $9K | Sell |
|
|||||
|
2021
Q3 | $180K | Hold |
|
|||||
|
2021
Q2 | $179K | Hold |
|
|||||
|
2021
Q1 | $150K | Buy |
|